At 11.6% CAGR, North America Hereditary Cancer Testing Market Size is Expected to Exhibit 3,247.37 million USD by 2027


(MENAFN- America News Hour) Adetailed study on 'North America Hereditary Cancer Testing market' formulated
by Market Study Report, LLC, puts together a concise analysis of the growth
factors impacting the current business scenario across assorted regions.
Significant information pertaining to the industry's size, share, application,
and statistics are also summed in the report in order to present an ensemble
prediction. In addition, this report undertakes an accurate competitive
analysis illustrating the status of market majors in the projection timeline,
while including their expansion strategies and portfolio.

The
North America hereditary cancer testing market is expected to reach US$
3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to
grow at a growth rate of 11.6% from 2019-2027. Some of the major primary and
secondary sources included in the report are, Food and Drug Administration,
World Health Organization (WHO), Centers for Medicare & Medicaid Services
(CMS), National Institute of Cancer Prevention and Research (NICPR), National
Cancer Institute, Canadian Institutes of Health Research (CIHR) and others.

Request
a sample of this premium report at
https://www.marketstudyreport.com/request-a-sample/2337532?utm_source=marketwatch.com & utm_medium=Abhijeet
 

The
growth of the hereditary cancer testing market is primarily attributed to
increasing as increasing prevalence of hereditary cancer and growing awareness
about hereditary cancer have been boosting the market over the years. On the
other hand, favorable reimbursement scenario is expected to have a positive
effect on the growth of the North America hereditary cancer testing market in
the coming years. Genetic testing helps evaluate the chance of developing
cancer in a lifetime. The genetic testing is done by searching for specific
mutations in genes, chromosomes, or proteins. An inherited gene mutation causes
hereditary cancer. An inherited gene is the one which is passed from parent to
child in a family. Various methods are used for hereditary cancer testing; it
includes genetic counseling.

The
counseling provides a discussion regarding recommendations for preventive care
and screening with the patient. They support groups and other information
resources and provide emotional support to the person getting the results. The
technological advances have allowed more significant integration of genomics
into health care delivery, facilitating screening and molecular diagnostics
along with the precise detection of microbes, and prescription and monitoring
of efficiency of more accurate therapeutics. The growing demand for noninvasive
method for cancer testing may stimulate market growth during the forecast
period.

North
America hereditary cancer testing market is segmented by diagnosis type,
technology, and end user. On the basis of diagnosis type, the market is
segmented into biopsy and imaging. On the basis of technology, the market is
segmented into sequencing, PCR, and microarray. Based on end user, the market
is segmented into diagnostic centers, hospital, and clinics. In 2018, the
imaging held the largest share in the market, by diagnosis type.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/2337532?utm_source=marketwatch.com & utm_medium=Abhijeet
TABLE OF CONTENTS

1.
Introduction

2.
North America Hereditary Cancer Testing Market -  Key Takeaways

3.
North America Hereditary Cancer Testing Market - Market Landscape

4.
North America Hereditary Cancer Testing Market - Key Market Dynamics

5.
Hereditary Cancer Testing Market - North America Analysis

6.
North America Hereditary Cancer Testing Market Analysis - By Diagnosis Type

7.
North America Hereditary Cancer Testing Market Analysis - By Technology

8.
North America Hereditary Cancer Testing Market Analysis - By End User

9.
North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027

10.
Hereditary Cancer Testing Market - Industry Landscape

11.
Hereditary Cancer Testing Market-Key Company Profiles

11.1
Hologic Inc.

11.1.1
Key Facts

11.1.2
Business Description

11.1.3
Financial Overview

11.1.4
Product Portfolio

11.1.5
SWOT Analysis

11.1.6
Key Developments

11.2
Koninklijke Philips N.V.

11.2.1
Key Facts

11.2.2
Business Description

11.2.3
Financial Overview

11.2.4
Product Portfolio

11.2.5
SWOT Analysis

11.2.6
Key Developments

11.3
Quest Diagnostics Incorporated

11.3.1
Key Facts

11.3.2
Business Description

11.3.3
Financial Overview

11.3.4
Product Portfolio

11.3.5
SWOT Analysis

11.3.6
Key Developments

11.4
Myriad Genetics, Inc.

11.4.1
Key Facts

11.4.2
Business Description

11.4.3
Financial Overview

11.4.4
Product Portfolio

11.4.5
SWOT Analysis

11.4.6
Key Developments

11.5
Cancer Genetics Inc.

11.5.1
Key Facts

11.5.2
Business Description

11.5.3
Financial Overview

11.5.4
Product Portfolio

11.5.5
SWOT Analysis

11.5.6
Key Developments

11.6
Invitae Corporation

11.6.1
Key Facts

11.6.2
Business Description

11.6.3
Financial Overview

11.6.4
Product Portfolio

11.6.5
SWOT Analysis

11.6.6
Key Developments

11.7
Myogenes

11.7.1
Key Facts

11.7.2
Business Description

11.7.3
Financial Overview

11.7.4
Product Portfolio

11.7.5
SWOT Analysis

11.7.6
Key Developments

11.8
Strand Life Sciences Pvt. Ltd.

11.8.1
Key Facts

11.8.2
Business Description

11.8.3
Financial Overview

11.8.4
Product Portfolio

11.8.5
SWOT Analysis

11.8.6
Key Developments

11.9
Pathway Genomics Corporation

11.9.1
Key Facts

11.9.2
Business Description

11.9.3
Financial Overview

11.9.4
Product Portfolio

11.9.5
SWOT Analysis

11.9.6
Key Developments

11.10
CENTOGENE AG

12.
Appendix

buying decision on this premium reporthttps://www.marketstudyreport.com/enquiry-before-buying/2337532?utm_source=marketwatch.com & utm_medium=Abhijeet
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Us:
Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:
Website: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog


Market Study Report LLC

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

MENAFN11112019007010068ID1099256702

-MENAFN11112019007010068ID1099256702-->


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.